Recent Finacing
Recent Raise
SynAgile develops and commercializes OraFuse noninvasive, continuous oral drug‑delivery therapeutics, including DopaFuse, a levodopa‑carbidopa system for Parkinson’s motor fluctuations currently in Phase II trials.
Focus Areas
Total Raised
Funding rounds
See the team members at SynAgile.
